Skip to content
← Back to this collection

PUBLICATIONS · 29242041

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Jan
First author
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jan;19(1):2-3. doi: 10.1016/S1470-2045(17)30914-2.
    note
    Source null
    related pmid
    29242042
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Mar;19(3):e128. doi: 10.1016/S1470-2045(18)30115-3.
    note
    Source null
    related pmid
    29508753
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2018 Mar;19(3):e129. doi: 10.1016/S1470-2045(18)30118-9.
    note
    Source null
    related pmid
    29508754
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2018 Mar;19(3):e130. doi: 10.1016/S1470-2045(18)30120-7.
    note
    Source null
    related pmid
    29508755
    relationship
    Comment in

Authors and identifiers

  1. name
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    type
    CollectiveName
bibliography ids
  1. nci-bib-14aa730ec20ae652d5b6210c
book metadata
content sha256
ab6d982e796f17de67ba6c7761154924296503a5e07cda6090ba75753823fc0e
document type
citation
dois
  1. 10.1016/S1470-2045(17)30777-5
electronic publication date
display
2017 Dec 11
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29242041
immutable id
pubmed:29242041@ab6d982e796f17de67ba6c7761154924296503a5e07cda6090ba75753823fc0e
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
27-39
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jan;19(1):2-3. doi: 10.1016/S1470-2045(17)30914-2.
    note
    Source null
    related pmid
    29242042
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Mar;19(3):e128. doi: 10.1016/S1470-2045(18)30115-3.
    note
    Source null
    related pmid
    29508753
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2018 Mar;19(3):e129. doi: 10.1016/S1470-2045(18)30118-9.
    note
    Source null
    related pmid
    29508754
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2018 Mar;19(3):e130. doi: 10.1016/S1470-2045(18)30120-7.
    note
    Source null
    related pmid
    29508755
    relationship
    Comment in
outcomes validated
false
pmid
29242041
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
5ca0b0563382f348e1c1ed2d5936b94d60fb0c6a0ab086155abfb7efbf76b917
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Jan
precision
month
year
2018
publication types
  1. Journal Article
  2. Meta-Analysis
  3. Research Support, Non-U.S. Gov't
  4. Review
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29242041/
title
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Preserved source evidence · Not medical advice